472 related articles for article (PubMed ID: 17286280)
1. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
[TBL] [Abstract][Full Text] [Related]
2. Biological activity of rainbow trout Ea4-peptide of the pro-insulin-like growth factor (pro-IGF)-I on promoting attachment of breast cancer cells (MDA-MB-231) via alpha2- and beta1-integrin.
Siri S; Chen MJ; Chen TT
J Cell Biochem; 2006 Dec; 99(6):1524-35. PubMed ID: 16817231
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human breast cancer cell (MBA-MD-231) invasion by the Ea4-peptide of rainbow trout pro-IGF-I.
Siri S; Chen MJ; Chen TT
J Cell Biochem; 2006 Dec; 99(5):1363-73. PubMed ID: 16795042
[TBL] [Abstract][Full Text] [Related]
4. Microinjecting recombinant rainbow trout Ea4-peptide of pro-IGF-I into zebrafish embryos causes abnormal development in heart, red blood cells, and vasculature.
Chun CZ; Chen TT
Comp Biochem Physiol C Toxicol Pharmacol; 2007 Feb; 145(1):39-44. PubMed ID: 16914384
[TBL] [Abstract][Full Text] [Related]
5. Development of rainbow trout hepatoma cell lines: effect of pro-IGF-I Ea4-peptide on morphological changes and anchorage-independent growth.
Chen MJ; Chiou PP; Yang BY; Lo HC; Son JK; Hendricks J; Bailey G; Chen TT
In Vitro Cell Dev Biol Anim; 2004; 40(3-4):118-28. PubMed ID: 15311963
[TBL] [Abstract][Full Text] [Related]
6. Trout Ea4- or human Eb-peptide of pro-IGF-I disrupts heart, red blood cell, and vasculature development in zebrafish embryos.
Chun CZ; Tsai HJ; Chen TT
Mol Reprod Dev; 2006 Sep; 73(9):1112-21. PubMed ID: 16807888
[TBL] [Abstract][Full Text] [Related]
7. Novel activities of pro-IGF-I E peptides: regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells.
Kuo YH; Chen TT
Exp Cell Res; 2002 Oct; 280(1):75-89. PubMed ID: 12372341
[TBL] [Abstract][Full Text] [Related]
8. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
9. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
10. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
11. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between LKB1 gene and invasion-related factors of breast cancer cells].
Zhuang ZG; Di GH; Hou YF; Liu G; Luo JM; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):81-4. PubMed ID: 17418010
[TBL] [Abstract][Full Text] [Related]
14. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
Thapa D; Lee JS; Heo SW; Lee YR; Kang KW; Kwak MK; Choi HG; Kim JA
Eur J Pharmacol; 2011 Jan; 650(1):64-71. PubMed ID: 20950604
[TBL] [Abstract][Full Text] [Related]
15. Production of bioactive recombinant human Eb-peptide of pro-IGF-I and identification of binding components from the plasma membrane of human breast cancer cells (MDA-MB-231).
Lo JH; Chen TT
Exp Cell Res; 2018 Jan; 362(1):235-243. PubMed ID: 29191552
[TBL] [Abstract][Full Text] [Related]
16. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
19. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC
Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
Gooch JL; Lee AV; Yee D
Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]